Gilles Berclaz

Summary

Affiliation: University Hospital
Country: Switzerland

Publications

  1. ncbi [Sentinel lymphadenectomy: an alternative to axillary lymphadenectomy in breast carcinoma]
    G Berclaz
    Universitats Frauenklinik, Inselspital Bern
    Schweiz Med Wochenschr 128:1730-6. 1998
  2. ncbi Hormone-dependent nuclear localization of the tyrosine kinase iyk in the normal human breast epithelium and loss of expression during carcinogenesis
    G Berclaz
    Department of Obstetrics and Gynecology, University Hospital, Berne, Switzerland
    Int J Cancer 85:889-94. 2000
  3. ncbi Estrogen dependent expression of the receptor tyrosine kinase axl in normal and malignant human breast
    G Berclaz
    Department of Obstetrics and Gynecology, University Hospital, Berne, Switzerland
    Ann Oncol 12:819-24. 2001
  4. ncbi EGFR dependent expression of STAT3 (but not STAT1) in breast cancer
    G Berclaz
    Department of Obstetrics and Gynecology, Inselspital, CH 3012 Berne, Switzerland
    Int J Oncol 19:1155-60. 2001
  5. ncbi Long-term follow-up of concurrent radiotherapy and chemotherapy for locally advanced cervical cancer: 12-Year survival after radiochemotherapy
    Gilles Berclaz
    Department of Obstetrics and Gynecology, University Hospital, Inselspital Bern, Schanzeneckstrasse 1, 3012, Switzerland
    Int J Oncol 20:1313-8. 2002
  6. ncbi Loss of EphB4 receptor tyrosine kinase protein expression during carcinogenesis of the human breast
    Gilles Berclaz
    Department of Obstetrics and Gynecology, Univeristy Hospital, Inselspital Berne, Schanzeneckstrasse 1, Switzerland
    Oncol Rep 9:985-9. 2002
  7. ncbi Activation of the receptor protein tyrosine kinase EphB4 in endometrial hyperplasia and endometrial carcinoma
    G Berclaz
    Department of Obstetrics and Gynecology, University Hospital, Berne, Switzerland
    Ann Oncol 14:220-6. 2003
  8. ncbi Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience
    G Berclaz
    Department of Obstetrics and Gynecology, Inselspital, Bern, Switzerland
    Ann Oncol 15:875-84. 2004
  9. ncbi Sites of failure in breast cancer patients with extracapsular invasion of axillary lymph node metastases. No need for axillary irradiation?!
    Günther Gruber
    Department of Radiation Oncology, Inselspital, University of Berne, Switzerland
    Strahlenther Onkol 181:574-9. 2005
  10. ncbi Can the addition of regional radiotherapy counterbalance important risk factors in breast cancer patients with extracapsular invasion of axillary lymph node metastases?
    Günther Gruber
    Department of Radiation Oncology, Inselspital, University of Bern, Switzerland
    Strahlenther Onkol 179:661-6. 2003

Detail Information

Publications17

  1. ncbi [Sentinel lymphadenectomy: an alternative to axillary lymphadenectomy in breast carcinoma]
    G Berclaz
    Universitats Frauenklinik, Inselspital Bern
    Schweiz Med Wochenschr 128:1730-6. 1998
    ..Sentinel lymph node biopsy is a new technique which allows accurate staging of breast carcinoma without performing total axillary dissection. We describe our experience with the introduction of sentinel lymphadenectomy...
  2. ncbi Hormone-dependent nuclear localization of the tyrosine kinase iyk in the normal human breast epithelium and loss of expression during carcinogenesis
    G Berclaz
    Department of Obstetrics and Gynecology, University Hospital, Berne, Switzerland
    Int J Cancer 85:889-94. 2000
    ..Our results indicate that iyk expression is gradually lost during carcinogenesis; thus, iyk may be classified as a tumor-suppressor gene...
  3. ncbi Estrogen dependent expression of the receptor tyrosine kinase axl in normal and malignant human breast
    G Berclaz
    Department of Obstetrics and Gynecology, University Hospital, Berne, Switzerland
    Ann Oncol 12:819-24. 2001
    ..In mice, axl is expressed in the normal mammary gland and over-expressed in aggressive mammary tumors...
  4. ncbi EGFR dependent expression of STAT3 (but not STAT1) in breast cancer
    G Berclaz
    Department of Obstetrics and Gynecology, Inselspital, CH 3012 Berne, Switzerland
    Int J Oncol 19:1155-60. 2001
    ....
  5. ncbi Long-term follow-up of concurrent radiotherapy and chemotherapy for locally advanced cervical cancer: 12-Year survival after radiochemotherapy
    Gilles Berclaz
    Department of Obstetrics and Gynecology, University Hospital, Inselspital Bern, Schanzeneckstrasse 1, 3012, Switzerland
    Int J Oncol 20:1313-8. 2002
    ..The psychological impact of this treatment should not be minimized. Most problems tend to diminish with time with the exception of intestinal side effects and vaginal changes...
  6. ncbi Loss of EphB4 receptor tyrosine kinase protein expression during carcinogenesis of the human breast
    Gilles Berclaz
    Department of Obstetrics and Gynecology, Univeristy Hospital, Inselspital Berne, Schanzeneckstrasse 1, Switzerland
    Oncol Rep 9:985-9. 2002
    ..002) suggesting that in breast cancer, EphB4 expression is not compatible with tumor progression. This raises the possibility that EphB4 could represent a potent tool for therapeutic intervention...
  7. ncbi Activation of the receptor protein tyrosine kinase EphB4 in endometrial hyperplasia and endometrial carcinoma
    G Berclaz
    Department of Obstetrics and Gynecology, University Hospital, Berne, Switzerland
    Ann Oncol 14:220-6. 2003
    ..Since the endometrium is a similarly hormone dependent organ and endometrial carcinoma is thought to result from estrogenic stimulation, we have investigated EphB4 expression in normal human endometrium and during its carcinogenesis...
  8. ncbi Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience
    G Berclaz
    Department of Obstetrics and Gynecology, Inselspital, Bern, Switzerland
    Ann Oncol 15:875-84. 2004
    ..Current information on the prognostic importance of body mass index (BMI) for patients with early breast cancer is based on a variety of equivocal reports. Few have data on BMI in relationship to systemic treatment...
  9. ncbi Sites of failure in breast cancer patients with extracapsular invasion of axillary lymph node metastases. No need for axillary irradiation?!
    Günther Gruber
    Department of Radiation Oncology, Inselspital, University of Berne, Switzerland
    Strahlenther Onkol 181:574-9. 2005
    ..Extracapsular spread (ECS) is frequent, but the specific sites of relapse are seldom given in the literature. In this study it was evaluated, if ECS might be an indicator for axillary irradiation...
  10. ncbi Can the addition of regional radiotherapy counterbalance important risk factors in breast cancer patients with extracapsular invasion of axillary lymph node metastases?
    Günther Gruber
    Department of Radiation Oncology, Inselspital, University of Bern, Switzerland
    Strahlenther Onkol 179:661-6. 2003
    ..To evaluate if locoregional radiotherapy (RT) versus local irradiation only can alter the pattern of failure in breast cancer patients with extranodal invasion...
  11. ncbi Tumor cell specific expression of MMP-2 correlates with tumor vascularisation in breast cancer
    Valentin Djonov
    Institute of Anatomy, University of Berne, CH 3012 Berne, Switzerland
    Int J Oncol 21:25-30. 2002
    ..Thus, MMP-2 expression by tumor cells may serve as indicator of strong angiogenic induction potential of breast tumor cells...
  12. ncbi Prognosis of dermal lymphatic invasion with or without clinical signs of inflammatory breast cancer
    Guenther Gruber
    Department of Radiation Oncology, Inselspital, University of Berne, Bern, Switzerland
    Int J Cancer 109:144-8. 2004
    ..The finding of dermal lymphatic tumor invasion predicts a high probability for node-positive disease...
  13. doi Tomosynthesis-guided vacuum-assisted breast biopsy: A feasibility study
    Christian Waldherr
    Breast Centre Bern Brustzentrum Bern, Division of Radiology and Nuclear Medicine, Klinik Engeried, Lindenhofgruppe, Riedweg 15, 3012 Bern, Bern, Switzerland
    Eur Radiol 26:1582-9. 2016
    ..Evaluation of feasibility and clinical performance of a tomosynthesis-guided vacuum-assisted breast biopsy (TVAB) system compared to Stereotaxy (SVAB)...
  14. pmc Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter?
    Günther Gruber
    Department of Radiation Oncology, University of Bern, Switzerland
    Breast Cancer Res 6:R191-8. 2004
    ..We investigated the role of hif-1alpha expression in patients with node-positive breast cancer...
  15. pmc Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients
    Igor Langer
    Department of Surgery, University Hospital Basel, Basel, Switzerland
    Ann Surg 245:452-61. 2007
    ..To assess the morbidity after sentinel lymph node (SLN) biopsy compared with SLN and completion level I and II axillary lymph node dissection (ALND) in a prospective multicenter study...
  16. ncbi Association of the presence of bone marrow micrometastases with the sentinel lymph node status in 410 early stage breast cancer patients: results of the Swiss Multicenter Study
    Igor Langer
    Department of Surgery, University Hospital Basel, Basel, Switzerland
    Ann Surg Oncol 14:1896-903. 2007
    ..It is unknown whether an association exists between the SLN status and the presence of bone marrow (BM) micrometastases. The objective of the present investigation was to evaluate whether or not such an association exists...
  17. ncbi [Breast cancer surgery]
    Georges Vlastos
    Service de Gynecologie, Unité de sénologie et d oncogynécologie chirurgicales, HUG, Geneve
    Rev Med Suisse 3:2389-90, 2392-5. 2007
    ..Sentinel node biopsy has already remplaced axillary lymph node dissection in the evaluation of the axilla. Local ablation of the tumor may be a valuable alternative to surgery in the future...